Study evaluates post-acute sequelae of COVID-19 in US university
Researchers examined the prevalence and predictors of long coronavirus disease (COVID) in a sample representing a Washington, DC University staff in the United States of America (USA).
Stay updated with breaking news from Postacute Sequelae. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Researchers examined the prevalence and predictors of long coronavirus disease (COVID) in a sample representing a Washington, DC University staff in the United States of America (USA).
Diagnosing long COVID is something of an art for doctors who, without any formal criteria, say they know it when they see it.
TUESDAY, May 31, 2022 (HealthDay News) -- Vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) offers partial protection in the postacute phase of the disease, according to a study
In a new report, researchers say the challenges of treating long COVID are amplified by a critical issue: we do not know what constitutes long COVID or how to formally diagnose it, an issue that is further exacerbated by limited research data of varying quality and consistency.
A recent study published in the Annals of Internal Medicine investigated the challenges and solutions associated with the unbiased estimation of post coronavirus disease 2019 (COVID-19) sequelae.